PuSH - Publication Server of Helmholtz Zentrum München

Methylglyoxal drives a distinct, nonclassical macrophage activation status.

Thromb. Haemost. 121, 1464-1475 (2021)
DOI PMC
Open Access Green as soon as Postprint is submitted to ZB.
Metabolic complications in diabetic patients are driven by a combination of increased levels of nutrients and the presence of a proinflammatory environment. Methylglyoxal (MG) is a toxic byproduct of catabolism and has been strongly associated with the development of such complications. Macrophages are key mediators of inflammatory processes and their contribution to the development of metabolic complications has been demonstrated. However, a direct link between reactive metabolites and macrophage activation has not been demonstrated yet. Here, we show that acute MG treatment activated components of the p38 MAPK pathway and enhanced glycolysis in primary murine macrophages. MG induced a distinct gene expression profile sharing similarities with classically activated proinflammatory macrophages as well as metabolically activated macrophages usually found in obese patients. Transcriptomic analysis revealed a set of 15 surface markers specifically upregulated in MG-treated macrophages, thereby establishing a new set of targets for diagnostic or therapeutic purposes under high MG conditions, including diabetes. Overall, our study defines a new polarization state of macrophages that may specifically link aberrant macrophage activation to reactive metabolites in diabetes.
Impact Factor
Scopus SNIP
Scopus
Cited By
Altmetric
5.249
0.000
1
Tags
Annotations
Special Publikation
Hide on homepage

Edit extra information
Edit own tags
Private
Edit own annotation
Private
Hide on publication lists
on hompage
Mark as special
publikation
Publication type Article: Journal article
Document type Scientific Article
Keywords Methylglyoxal ; Macrophage Polarization ; Diabetes ; Metabolic Activation
Language english
Publication Year 2021
HGF-reported in Year 2021
ISSN (print) / ISBN 0340-6245
Quellenangaben Volume: 121, Issue: 11, Pages: 1464-1475 Article Number: , Supplement: ,
Publisher Schattauer
Publishing Place Rudigerstr 14, D-70469 Stuttgart, Germany
Reviewing status Peer reviewed
POF-Topic(s) 90000 - German Center for Diabetes Research
Research field(s) Helmholtz Diabetes Center
PSP Element(s) G-501900-251
Grants Deutsches Zentrum fur Herz-Kreislauf-Forschung Junior Research Group grant
Deutsche Forschungsgemeinschaft
Helmholtz Future Topic AMPro
Collaborative Research Center "Reactive metabolites and diabetic complications"
Scopus ID 85105803119
PubMed ID 33966256
Erfassungsdatum 2021-05-26